ArticleTherapeutic advances in gastroenterology2016
A novel schedule of erlotinib/capecitabine (7/7) as salvage therapy in previously treated advanced pancreatic adenocarcinoma: a case series.
Jiezhong Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.